Puhlmann Markus
Transaction: 03/02/2026
BUY
Change
+150,000
Price
$5.35
Filing
03/04/2026
Type
BUY
Perspective Therapeutics, Inc.
CATX • Medical - Devices
$3.20
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$358.96M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 5.17Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:55 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.20
Change0.00%
Shares Out112.17M
Market Cap$358.96M
Enterprise Value$124.45M
52W Range1.96 - 6.16
Beta1.75
P/E-3.08
P/S1,717.50
P/B1.11
P/FCF-2.96
EV/Sales595.44
Price$3.20
Change0.00%
Shares Out112.17M
Market Cap$358.96M
Enterprise Value$124.45M
52W Range1.96 - 6.16
Beta1.75
P/E-3.08
P/S1,717.50
P/B1.11
P/FCF-2.96
EV/Sales595.44
EV/EBITDA-1.43
EV/FCF-1.03
Earnings Yield-32.44%
FCF Yield-33.76%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio5.17
Quick Ratio5.17
Revenue 5Y-100.00%
Target$11.50
Target Upside259.38%
Target Median$11.50
Target Range11.00 - 12.00
Volume1.32M
Avg Volume1.57M
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 5.17Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 12 analyst votes · 2026-09-04
92/100
Bullish
Bullish
10
Hold
2
Bearish
0
Price Target
2026-08-14
Low
$12.00
Mean
$14.00
Median
$14.00
High
$16.00
Insider Transactions
Recent executive and insider activity
Hunt Jonathan Robert
Transaction: 03/02/2026
BUY
Change
+90,000
Price
$5.35
Filing
03/04/2026
Type
BUY
Spoor Johan M.
Transaction: 03/02/2026
BUY
Change
+735,000
Price
$5.35
Filing
03/04/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Puhlmann Markus | BUY | +150,000 | $5.35 | 03/02/2026 | 03/04/2026 |
| Hunt Jonathan Robert | BUY | +90,000 | $5.35 | 03/02/2026 | 03/04/2026 |
| Spoor Johan M. | BUY | +735,000 | $5.35 | 03/02/2026 | 03/04/2026 |
| Woods Lori A | BUY | +50,000 | $5.35 | 03/02/2026 | 03/04/2026 |
| HENSON HEIDI | BUY | +50,000 | $5.35 | 03/02/2026 | 03/04/2026 |
| Williamson Robert F III | BUY | +50,000 | $5.35 | 03/02/2026 | 03/04/2026 |
| Morich Frank | BUY | +50,000 | $5.35 | 03/02/2026 | 03/04/2026 |
| Martinez Maria E | BUY | +50,000 | $5.35 | 03/02/2026 | 03/04/2026 |
| Hunt Jonathan Robert | BUY | +11,000 | $2.03 | 11/13/2025 | 11/17/2025 |
| Williamson Robert F III | BUY | +9,498 | $2.10 | 11/12/2025 | 11/14/2025 |
| Sendek Joel | OTHER | 0 | Not reported | 09/04/2025 | 09/05/2025 |
| Sendek Joel | BUY | +600,000 | $3.54 | 09/04/2025 | 09/05/2025 |
| Martinez Maria E | OTHER | 0 | Not reported | 09/03/2025 | 09/05/2025 |
| Martinez Maria E | BUY | +75,000 | $3.38 | 09/03/2025 | 09/05/2025 |
| Woods Lori A | BUY | +23,475 | $2.13 | 03/31/2025 | 04/01/2025 |
| Williamson Robert F III | BUY | +38,145 | $2.14 | 03/31/2025 | 04/01/2025 |
| Graham Juan | BUY | +33,333 | $2.25 | 03/28/2025 | 04/01/2025 |
| Williamson Robert F III | BUY | +22,192 | $2.27 | 03/28/2025 | 04/01/2025 |
| Spoor Johan M. | BUY | +4,650 | $2.21 | 03/28/2025 | 04/01/2025 |
| Woods Lori A | BUY | +50,000 | $2.46 | 03/03/2025 | 03/05/2025 |